Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

Also called NCT06083337

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06083337
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Greece (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06083337. Randomized; no masking; primary purpose prevention. Start 2022-01-22 (actual); primary completion 2025-07-22 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography
Acronym
VIRDICT
Condition
Atheroscleroses, Coronary
Condition
Vascular Inflammation
Intervention (Device)
CaRi-Heart device
Lead sponsor
Hippocration General Hospital (class: other)
Collaborator
Biomedical Research Foundation, Academy of Athens (class: other)

Record details

Record id
cardio:ct-nct06083337
Content hash
2f5694b272a6d060045c2e871fde5ce1c78ad528c5e0d3b595969a65eb2f74e9